Cohen Announces $1 Million for Memphis-based Small Business

[WASHINGTON, DC] – Congressman Steve Cohen (TN-09) announced today that Immuno Technologies, Inc., a medical research and development company headquartered in Memphis, has been awarded $1,000,000 in federal funding to further develop technology that can help doctors rapidly diagnose Lyme disease. This funding comes through the National Institutes of Health’s (NIH) Small Business Innovation Research (SBIR) grant program.

“This funding will support an innovative Memphis small business developing new technology to help with rapid diagnosis and treatment of Americans suffering from Lyme disease,” said Congressman Cohen.

“We are grateful for this opportunity made possible by the SBIR/STTR Program at NIH/NIAID” said Dr. Maria Gomes-Solecki, President and CEO of Immuno Technologies, Inc.

Immuno Technologies, Inc. does translational research for infectious diseases, with a focus on Lyme disease. This grant will fund the development of a lab on a chip point-of-care assay for the rapid diagnosis of Lyme disease.

The SBIR grant program helps fund small business research and development projects that have the potential for commercialization. The program aims to stimulate technological innovation, strengthen the role of small business in meeting Federal research and development needs, and encourage participation by socially or economically disadvantaged small businesses concerns and women-owned businesses.